KENNETH BATE
CIK 1210238 · President & CEO · last filed 2026-01-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.97M
Companies
12
Total Filings
88
Lifetime Open-Market Net
-$29.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. (ATXS) Delisted | Director | — | $12.58 | — | $0 | 6 | 2026-01-23 |
| MDGL | Director | 2,657 | $480.77 | $1.28M | -$27.02M | 15 | 2025-11-07 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | 375 | $15.00 | $5.6K | $0 | 14 | 2023-01-19 |
| Epizyme, Inc. (EPZM) Delisted | Director | 17,054 | $1.47 | $25.1K | $0 | 9 | 2022-05-19 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | — | $0.00 | — | $0 | 8 | 2021-07-02 |
| Astria Therapeutics, Inc. (CATB) Delisted | Director | — | $8.54 | — | $0 | 7 | 2021-06-02 |
| VNDA | Director | 5,000 | $5.87 | $29.4K | $0 | 3 | 2017-06-19 |
| BMRN | Director | 11,875 | $55.95 | $664.4K | $0 | 5 | 2015-06-18 |
| CUBIST PHARMACEUTICALS INC (CBST.Z) Delisted | Director | 0 | — | — | -$2.00M | 4 | 2015-01-21 |
| CUBIST PHARMACEUTICALS INC (CBST) Delisted | Director | 7,914 | — | — | -$495.9K | 11 | 2013-06-14 |
| NITROMED INC (NTMD) Delisted | President & CEO | — | — | — | $0 | 2 | 2008-02-14 |
| Coley Pharmaceutical Group, Inc. (COLY) Delisted | Director | — | — | — | $0 | 1 | 2007-06-15 |
Recent Filings · Page 2 of 9
88 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-06 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Disp (D) | −375 | -$5.6K | EDGAR |
| 2022-08-16 | — | Disp (D) | −17,054 | $0 | |
| 2022-06-21 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | MDGL | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Astria Therapeutics, Inc. (ATXS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-08 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-19 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | +8,994 | $0 | EDGAR |
| 2021-07-02 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | MDGL | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.